Tsetan D. Sadutshang

Dharamsala, HP 176219, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Comprehensive tuberculosis screening and preventive treatment in schools and congregate settings of India (2017-2024): a prospective study.

Comprehensive tuberculosis screening and preventive treatment in schools and congregate settings of India (2017-2024): a prospective study.

Journal: The Lancet regional health. Southeast Asia

Published: August 24, 2025

Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India.

Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India.

Journal: Vaccine

Published: December 04, 2023

First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India.

First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India.

Journal: BMJ global health

Published: December 12, 2021

No Detectable Electroencephalographic Activity After Clinical Declaration of Death Among Tibetan Buddhist Meditators in Apparent Tukdam, a Putative Postmortem Meditation State.

No Detectable Electroencephalographic Activity After Clinical Declaration of Death Among Tibetan Buddhist Meditators in Apparent Tukdam, a Putative Postmortem Meditation State.

Journal: Frontiers in psychology

Published: August 26, 2020

Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessment.

Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessment.

Journal: PLoS medicine

Published: July 15, 2020

High prevalence of rifampin-resistant tuberculosis in mountainous districts of India.

High prevalence of rifampin-resistant tuberculosis in mountainous districts of India.

Journal: The Indian journal of tuberculosis

Published: May 31, 2019

High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee Children.

High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee Children.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: August 24, 2018

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.

Journal: Emerging infectious diseases

Published: August 01, 2017

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

Journal: The European respiratory journal

Published: February 23, 2017

Is mercury in Tibetan Medicine toxic? Clinical, neurocognitive and biochemical results of an initial cross-sectional study.

Is mercury in Tibetan Medicine toxic? Clinical, neurocognitive and biochemical results of an initial cross-sectional study.

Journal: Experimental biology and medicine (Maywood, N.J.)

Published: October 15, 2016

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine.

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine.

Journal: The European respiratory journal

Published: August 03, 2016

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline.

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline.

Journal: The European respiratory journal

Published: March 30, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026